News
CytoMed Therapeutics (NASDAQ:GDTC) CytoMed Therapeutics (GDCT, or the Company), a Singapore-based biotechnology company trading on the NASDAQ, is developing multiple gamma delta chimeric antigen...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Andrew Hecht is a 35-year Wall Street veteran covering commodities and precious metals. He runs the investing group...
News
Market Review North America U.S. Real Estate Investment Trusts (REITs) remain attractively priced, trading at about a 6% discount to net asset value (NAV),...
News
Follow Play Earnings CallPlay Earnings Call Birkenstock Holding plc (BIRK) Q4 2025 Earnings Call December 18, 2025 8:00 AM EST Company Participants Megan Kulick...
News
Atai Life Sciences (NASDAQ:ATAI) has been making great progress in advancing several drugs from its pipeline on multiple fronts. In particular, it is advancing...
News
More than a year ago, the Federal Trade Commission sued Intuit Inc., the maker of TurboTax, for allegedly tricking people into thinking they could...
News
Intro Winnebago Industries, Inc. (NYSE:WGO), based in Minnesota, has been making recreational vehicles since 1958. They generated around $5 billion in revenue as of...
News
After the recent pullback in its unit price, I now consider Dorchester Minerals, L.P. (NASDAQ:DMLP) undervalued after previously having a hold rating on it....
News
Dear Quentin, I have spoken with an attorney, but I see several online will services that are very inexpensive that include a will and...
News
One of the things that makes investing difficult is the fact that circumstances can change. Sometimes, those changes can occur rather rapidly. And when...
News
Not only are interest rates in the U.S. at their highest level in decades, the yield curve is inverted. Three-month U.S. Treasury bills BX:TMUBMUSD03M...
News
Federal Reserve Chairman Jay Powell, in his speech at Jackson Hole, assured the world that the Fed would do what was necessary to bring...
News
Summary I am following up on my previous coverage on Samsara (NYSE:IOT), where I recommended a hold rating as I believed there were a...
